Guarana (Paullinia cupana)

Guarana (Paullinia cupana) is an Amazonian plant containing 3-7% caffeine by weight, significantly higher than coffee beans. The seeds also contain catechin and epicatechin flavonoids that may modulate caffeine's effects.

Origin & History

Guarana is a climbing woody vine native to the Amazon basin of South America, particularly Brazil, where it has been cultivated for centuries. The active ingredient is extracted from the seed using ethanol or ethyl acetate solvents, with standardized extracts containing a minimum of 1.6% caffeine content.

Historical & Cultural Context

The research dossier does not provide historical context regarding guarana's use in traditional medicine systems or the specific conditions it was traditionally used to treat. While noted as cultivated in Brazil for centuries, no traditional use documentation is included in the available sources.

Health Benefits

• No clinical health benefits can be cited as the research dossier contains no human clinical trials or outcome data
• The seeds contain high concentrations of caffeine, a known stimulant (chemical analysis only)
• Contains flavan-3-ols including catechin and epicatechin (chemical composition data only)
• Contains theobromine, a methylxanthine compound (chemical analysis only)
• Manufacturing standards exist for extract potency, but no efficacy data is available

How It Works

Guarana's high caffeine content (3-7% by weight) blocks adenosine A1 and A2A receptors, preventing drowsiness and promoting alertness. The catechin and epicatechin flavonoids may slow caffeine absorption and metabolism, potentially extending its stimulant effects compared to pure caffeine.

Scientific Research

The provided research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses evaluating guarana's clinical efficacy. The available sources focus exclusively on extraction methodology and chemical composition analysis rather than clinical outcomes.

Clinical Summary

No human clinical trials have been conducted specifically on guarana extract or its health benefits. Current evidence is limited to chemical analysis showing caffeine concentrations of 30-70mg per gram of seed. The presence of flavan-3-ols like catechin and epicatechin has been confirmed through laboratory analysis, but their bioactivity in humans remains unstudied.

Nutritional Profile

Guarana seeds are nutritionally dense with bioactive compounds dominating the profile. Caffeine is the primary bioactive constituent, present at exceptionally high concentrations of 2–8% dry weight (seeds), significantly exceeding coffee beans at 1–2.5%, making it one of the most caffeine-rich natural sources known. Theobromine is present at approximately 0.02–0.04% dry weight, a methylxanthine with milder stimulant properties than caffeine. Theophylline occurs in trace quantities (<0.01% dry weight). Flavan-3-ols (condensed tannins/proanthocyanidins) constitute a major fraction at approximately 5–6% dry weight, with catechin and epicatechin as the primary monomeric units; these tannins significantly bind to and slow caffeine release, modulating absorption kinetics compared to free caffeine sources. Total tannin content (including catechins, epicatechins, and polymeric proanthocyanidins) can reach 9–12% dry weight. Saponins are present at approximately 0.2–0.4% dry weight. Fat content of the seed is approximately 3% dry weight, predominantly unsaturated fatty acids. Protein content is approximately 9–11% dry weight in raw seed meal. Starch and carbohydrates constitute approximately 8–12% dry weight. Fiber content is moderate at approximately 6–9% dry weight. Minerals present include potassium, phosphorus, magnesium, and calcium in modest amounts typical of seeds, though precise concentrations vary by origin and are not consistently reported in standardized references. Bioavailability note: the dense tannin matrix of the seed coat and seed structure slows caffeine absorption compared to coffee, producing a more gradual and prolonged stimulant effect according to chemical and pharmacokinetic studies; the tannin binding also reduces bioavailability of minerals co-ingested. Commercial guarana extracts are typically standardized to 22% caffeine content, though whole seed powder and beverages vary widely.

Preparation & Dosage

No clinically studied dosage ranges are available in the research provided. Manufacturing specifications require a minimum of 1.6% caffeine content in standardized extracts, but this represents a manufacturing standard rather than a clinical dosing recommendation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research data to recommend synergistic combinations

Safety & Interactions

Guarana's high caffeine content may cause jitters, insomnia, increased heart rate, and anxiety, especially in sensitive individuals. It can interact with blood thinners like warfarin and may enhance effects of other stimulants. Pregnant and breastfeeding women should limit intake due to caffeine content. Individuals with heart conditions should consult healthcare providers before use.